Shanghai Junshi Biosciences Co., Ltd. (1877.HK)

HKD 16.26

(-0.49%)

Long Term Debt Summary of Shanghai Junshi Biosciences Co., Ltd.

Shanghai Junshi Biosciences Co., Ltd.'s latest annual long term debt in 2023 was 1.21 Billion CNY , up 36.91% from previous year.
Shanghai Junshi Biosciences Co., Ltd.'s latest quarterly long term debt in 2024 Q2 was 1.74 Billion CNY , up 4.77% from previous quarter.
Shanghai Junshi Biosciences Co., Ltd. reported annual long term debt of 886.16 Million CNY in 2022, up 51.97% from previous year.
Shanghai Junshi Biosciences Co., Ltd. reported annual long term debt of 583.12 Million CNY in 2021, up 1.73% from previous year.
Shanghai Junshi Biosciences Co., Ltd. reported quarterly long term debt of 1.74 Billion CNY for 2024 Q2, up 4.77% from previous quarter.
Shanghai Junshi Biosciences Co., Ltd. reported quarterly long term debt of 1.06 Billion CNY for 2023 Q3, up 10.57% from previous quarter.

Annual Long Term Debt Chart of Shanghai Junshi Biosciences Co., Ltd. (2023 - 2014)

Historical Annual Long Term Debt of Shanghai Junshi Biosciences Co., Ltd. (2023 - 2014)

Year	Long Term Debt	Long Term Debt Growth
2023	1.21 Billion CNY	36.91%
2022	886.16 Million CNY	51.97%
2021	583.12 Million CNY	1.73%
2020	573.21 Million CNY	-25.77%
2019	772.22 Million CNY	97.12%
2018	391.76 Million CNY	0.0%
2017	- CNY	0.0%
2016	- CNY	0.0%
2015	- CNY	0.0%
2014	- CNY	0.0%

Year	Long Term Debt	Long Term Debt Growth
2024 Q1	1.67 Billion CNY	38.75%
2024 Q2	1.74 Billion CNY	4.77%
2023 Q3	1.06 Billion CNY	10.57%
2023 Q4	1.21 Billion CNY	13.46%
2023 FY	1.21 Billion CNY	36.91%
2023 Q1	942.96 Million CNY	6.41%
2023 Q2	967.09 Million CNY	2.56%
2022 FY	886.16 Million CNY	51.97%
2022 Q4	886.16 Million CNY	-2.93%
2022 Q3	912.89 Million CNY	8.81%
2022 Q2	839.01 Million CNY	47.49%
2022 Q1	568.85 Million CNY	-2.45%
2021 Q3	580.59 Million CNY	61.44%
2021 Q4	583.12 Million CNY	0.44%
2021 Q1	598.4 Million CNY	4.39%
2021 FY	583.12 Million CNY	1.73%
2021 Q2	359.63 Million CNY	-39.9%
2020 Q1	- CNY	-100.0%
2020 FY	573.21 Million CNY	-25.77%
2020 Q2	763.89 Million CNY	0.0%
2020 Q3	771.31 Million CNY	0.97%
2020 Q4	573.21 Million CNY	-25.68%
2019 Q1	535.7 Million CNY	36.74%
2019 FY	772.22 Million CNY	97.12%
2019 Q4	772.22 Million CNY	0.0%
2019 Q2	419.92 Million CNY	-21.61%
2018 Q3	213.98 Million CNY	2.09%
2018 FY	391.76 Million CNY	0.0%
2018 Q4	391.76 Million CNY	83.08%
2018 Q2	209.6 Million CNY	0.0%
2018 Q1	- CNY	0.0%
2017 FY	- CNY	0.0%
2017 Q1	- CNY	0.0%
2017 Q2	- CNY	0.0%
2017 Q4	- CNY	0.0%
2016 FY	- CNY	0.0%
2016 Q1	- CNY	0.0%
2016 Q2	- CNY	0.0%
2016 Q3	- CNY	0.0%
2016 Q4	- CNY	0.0%
2015 Q2	- CNY	0.0%
2015 Q1	- CNY	0.0%
2015 Q4	- CNY	0.0%
2015 Q3	- CNY	0.0%
2015 FY	- CNY	0.0%
2014 FY	- CNY	0.0%
2014 Q4	- CNY	0.0%
2014 Q3	- CNY	0.0%

Peer Long Term Debt Comparison of Shanghai Junshi Biosciences Co., Ltd.

Name	Long Term Debt	Long Term Debt Difference
Uni-Bio Science Group Limited	30.61 Million HKD	-3863.299%
CK Life Sciences Int'l., (Holdings) Inc.	4.27 Billion HKD	71.606%